Intensity Modulated Radiotherapy for Breast Cancer

Completed · Phase 1

Conditions studied: Breast Cancer

In brief

This study delivers radiation therapy to any residual breast tissue and the chest wall plus lymph node areas around the breast. These lymph node areas are under the arm, around the collar bone, and under the sternum (breastbone).

Key facts

Study ID

NCT00594477

Run by

Washington University School of Medicine

People needed

100

Starts

2008-01-04

Expected to finish

2016-08-08

Last updated by the study team

2017-08-10

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female gender
• Age ≥ 18 years
• Invasive primary female breast cancer
• Pathologically proven regional nodal metastasis
• Status post mastectomy or partial mastectomy with an assessment of axillary nodes via sentinel lymph node biopsy and/or axillary lymph node dissection.
• Signed study specific consent form

You may not qualify if…

• Distant metastasis
• Currently Pregnant
• Psychiatric or addictive disorders that preclude informed consent
• Time from initial diagnosis to the start of radiation therapy > one year
• Estimated life expectancy judged to be < one year
• Prior radiation to the ipsilateral breast or chest wall
• Primary breast cancer is lymphoma or sarcoma
• Patients being treated with concurrent chemotherapy.

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.